The European Medicines Agency defines Good Distribution Practice (GDP) as “the minimum standards that a wholesale distributor must meet to ensure that the quality and integrity of medicines is maintained throughout the supply chain.”
The purpose of conducting a GDP audit is to ensure that the auditee has implemented the correct processes to maintain the quality and integrity of the medicinal product throughout its supply chain.